In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Watson gets rights to Itero's rFSH for female infertility

Executive Summary

Watson Pharmaceuticals Inc. (generics and branded urology and women's health products) has received exclusive worldwide rights to Itero Biopharmaceuticals Inc.'s (protein therapeutics) recombinant follicle-stimulating hormone (rFSH), which is in preclinical studies for female infertility.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R&D and Marketing (Licensing)

Related Companies